High-Purity Trans-4-Dimethylaminocrotonic Acid Hydrochloride: Key Afatinib Intermediate Manufacturer and Supplier

Discover the critical pharmaceutical intermediate, Trans-4-Dimethylaminocrotonic Acid Hydrochloride (CAS 848133-35-7), essential for the synthesis of Afatinib. As a leading supplier, we offer high-purity material with consistent quality, supporting your research and manufacturing needs with competitive pricing and reliable global supply.

Get a Quote & Sample

Advantages of Partnering with Us for Your Chemical Needs

Uncompromised Quality Assurance

We adhere to stringent quality control measures, ensuring every batch of Trans-4-Dimethylaminocrotonic Acid Hydrochloride meets precise specifications for your pharmaceutical synthesis projects. Buy with confidence from a reputable supplier.

Competitive Pricing for Bulk Purchases

As a direct manufacturer, we offer competitive pricing for Trans-4-Dimethylaminocrotonic Acid Hydrochloride, making it cost-effective for both R&D and large-scale production. Request a quote today to discuss your bulk purchase needs.

Stable and Consistent Supply

We maintain robust production capabilities to ensure a stable and consistent supply of this key Afatinib intermediate. Count on us as your reliable chemical manufacturer and supplier for uninterrupted project timelines.

Key Applications and Uses

Afatinib Synthesis Intermediate

Trans-4-Dimethylaminocrotonic Acid Hydrochloride is a crucial intermediate in the chemical synthesis of Afatinib, an important anti-cancer drug. Its reliable availability is key for pharmaceutical manufacturers.

Organic Synthesis Reagent

This compound serves as a valuable building block in various organic synthesis pathways, enabling the creation of complex molecules for advanced research and development.

Pharmaceutical Research & Development

Essential for R&D departments exploring novel drug candidates and optimizing existing pharmaceutical formulations, this intermediate is a cornerstone for innovation.

Tyrosine Kinase Inhibitor Development

Its structural properties make it a key component in the development of tyrosine kinase inhibiting antitumor agents, driving progress in targeted cancer therapies.